ClinicalTrials.Veeva

Menu

Inappropriate Sinus Tachycardia Registry

AtriCure logo

AtriCure

Status

Enrolling

Conditions

Postural Tachycardia Syndrome
Inappropriate Sinus Tachycardia

Treatments

Device: AtriCure Commercially Available Devices

Study type

Observational

Funder types

Industry

Identifiers

NCT05107635
RP-2021-IST

Details and patient eligibility

About

The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subject is scheduled to undergo or has undergone a procedure to treat IST or POTS using one or more AtriCure devices.
  2. Subject is willing to provide written informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this Registry) or authorization per institution and geographical requirements

Exclusion criteria

  1. Subject is enrolled in a concurrent study that may impact treatment outcome of IST or POTS.
  2. Subject with exclusion criteria required by FDA or local governance

Trial contacts and locations

10

Loading...

Central trial contact

Registry Specialist

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems